Clinical Trial Update: Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's Disease [NA]

View source ↗

Summary

Clinical trial update for Rituxan with BEAM and autologous stem cell transplant in high-risk lymphoma or Hodgkin's disease; trial completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Lymphoma

Drugs mentioned

• BEAM
• Rituxan (rituximab)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Lymphoma, Hodgkin's Disease | NA | Status: COMPLETED | Results posted: 2015-09-28